CluenexHuntsman Corporation HUN
Huntsman Corporation scores weak on business quality (1.9 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Huntsman Corporation does
Huntsman manufactures differentiated organic chemical products, selling polyurethanes, performance products, and advanced materials to industrial customers for use in automotive, construction, and coating applications. The company is navigating a prolonged demand slump across its core chemical segments, pushing management to focus on cost containment and asset footprint reduction.
- What it does best
Huntsman holds specialized manufacturing expertise in polyurethane formulations, though its metrics show no standout operational edge with a gross margin of 13.5 percent. Without proprietary tech or high switching costs, competitors easily match its commodity-like chemical outputs.
- The main risk
A negative interest coverage ratio of -0.2x means operating income fails to cover debt servicing costs, leaving the balance sheet vulnerable if chemical demand fails to recover. Total debt sits at $2.0B against a cash pile of $429 million, limiting financial flexibility.
Quality, check by check
Scored against its own industry, from company filings.
An operating margin of -0.3 percent and negative return on equity of -6.7 percent show persistent unprofitability as scaling fails to cover costs.
Operating in the bottom quartile for gross margin and revenue growth, Huntsman lacks a durable moat to protect pricing power from rivals.
Revenue contracted by 5.8 percent to $5.9B, marking a continued downward trend from 2022 highs as end-market demand shrinks.
Net debt climbs to $1.6B while free cash flow dips to -$9.0M, signaling a softening financial position under heavy debt loads.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
1 insider bought $981K on the open market.
Our sealed record on HUN
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Huntsman Corporation scores weak on the Cluenex quality check (1.9 of 10), measured against its own industry. Profitability is weak, moat weak, growth slow and financial health weak.
In the last 90 days of SEC Form 4 filings: 1 insider bought $981K on the open market.
Nov 2, 2026, after the close.
See HUN today
- Today's verdict on HUN, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Huntsman Corporation (HUN)”, https://cluenex.com/stocks/hun/, data as of Oct 10, 2026.